Retraction notice to "Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16" [Life Sci. 225 (2019) 55-63].

Wei, Yuzhen; Wang, Fang; Sang, Ben; Xu, Zhen; Yang, Dongxu

Wei, Yuzhen; Wang, Fang; Sang, Ben; Xu, Zhen; Yang, Dongxu.

Afiliación

Wei Y; Department of Neurosurgery, Jining No.1 People's Hospital, Jining 272011, China; Affiliated Jining No.1 People's Hospital of Jining Medical University, Jining Medical University, Jining 272067, China.
Wang F; Department of Pathology, Jining No.1 People's Hospital, Jining 272011, China.
Sang B; Department of Neurosurgery, Jining No.1 People's Hospital, Jining 272011, China.
Xu Z; Department of Neurosurgery, Jining No.1 People's Hospital, Jining 272011, China.
Yang D; Department of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining 272000, China.

Life Sci ; 256: 117903, 2020 09 01.

Article en En | MEDLINE | ID: mdl-32565234

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Life Sci Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Life Sci Año: 2020 Tipo del documento: Article País de afiliación: China